ANTXR1 and hemangioma: It appears that suppressed β1 integrin activation in all ECs isolated from proliferating hemangioma lesions (hemECs) is associated with increased interactions between several components of the VEGFR2/TEM8/β1 integrin complex, which most likely also contains other components, which are not yet identified [67,68].